Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2022

18.06.2021 | Research Communication

Survival Outcomes for Colorectal Cancer with Isolated Liver Metastases at Academic Versus Community Hospitals

verfasst von: Vanessa M. Welten, Adam C. Fields, James Yoo, Jennifer L. Irani, Joel E. Goldberg, Ronald Bleday, Nelya Melnitchouk

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Colorectal cancer is the third leading cause of cancer-related deaths in the USA. Twenty to twenty-five percent of patients with colorectal cancer present with metastatic disease at diagnosis, with liver being the most common site of distant metastasis. 13 Survival has greatly improved over time with the introduction of metastasectomy, with 5-year survival rates ranging from 38 to as high as 58%. 46 Hepatic resection is now the treatment of choice for isolated resectable colorectal liver metastases. 5 We aim to compare outcomes for patients with stage IV colon and rectal cancer with isolated liver metastases treated at academic versus community hospitals. …
Literatur
5.
Zurück zum Zitat NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Colon Cancer2021 January 21 2021. NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Colon Cancer2021 January 21 2021.
Metadaten
Titel
Survival Outcomes for Colorectal Cancer with Isolated Liver Metastases at Academic Versus Community Hospitals
verfasst von
Vanessa M. Welten
Adam C. Fields
James Yoo
Jennifer L. Irani
Joel E. Goldberg
Ronald Bleday
Nelya Melnitchouk
Publikationsdatum
18.06.2021
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2022
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-021-05062-6

Weitere Artikel der Ausgabe 1/2022

Journal of Gastrointestinal Surgery 1/2022 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.